Literature DB >> 15487450

Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma.

Richard A Scolyer1, Ling-Xi L Li, Stanley W McCarthy, Helen M Shaw, Jonathan R Stretch, Raghwa Sharma, John F Thompson.   

Abstract

The aim of the present study was to determine whether micromorphometric features of positive sentinel lymph nodes (SLNs) from patients with melanoma are useful for predicting further nodal involvement in completion lymph node dissection (CLND) specimens. Of 986 patients with melanoma undergoing SLN biopsy between March 1992 and February 2001, 175 (17.7%) had at least 1 positive SLN and 140 had subsequent CLND specimens available for review. Further nodal involvement in CLND specimens was present in 24 (17.1%) of 140 patients. Of 8 micromorphometric features of the SLNs that were assessed, the presence of metastases in CLND specimens was correlated significantly with a tumor penetrative depth (maximum distance of melanoma cells from the inner margin of the SLN capsule) of more than 2 mm (P < .05), a deposit size of more than 10 mm2 (P < .01), the presence of melanoma cells in perinodal lymphatic vessels (P < .01), and the effacement of nodal architecture by metastatic melanoma cells (P < .05). Our results indicate that some morphologic features of melanoma metastases in SLNs predict the likelihood of further nodal involvement in CLND specimens.

Entities:  

Mesh:

Year:  2004        PMID: 15487450     DOI: 10.1309/TDWJ-TR15-TDM1-TG7Q

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  14 in total

1.  Low incidence of nonsentinel node-positivity after complete lymph node dissection in melanoma patients with positive sentinel nodes.

Authors:  Arata Tsutsumida; Hiroshi Furukawa; Yuhei Yamamoto; Katsumi Horiuchi; Tetsunori Yoshida; Satoru Fujii
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

2.  EANM-EORTC general recommendations for sentinel node diagnostics in melanoma.

Authors:  Annette H Chakera; Birger Hesse; Zeynep Burak; James R Ballinger; Allan Britten; Corrado Caracò; Alistair J Cochran; Martin G Cook; Krzysztof T Drzewiecki; Richard Essner; Einat Even-Sapir; Alexander M M Eggermont; Tanja Gmeiner Stopar; Christian Ingvar; Martin C Mihm; Stanley W McCarthy; Nicola Mozzillo; Omgo E Nieweg; Richard A Scolyer; Hans Starz; John F Thompson; Giuseppe Trifirò; Giuseppe Viale; Sergi Vidal-Sicart; Roger Uren; Wendy Waddington; Arturo Chiti; Alain Spatz; Alessandro Testori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10       Impact factor: 9.236

Review 3.  Treatment strategy for cutaneous malignant melanoma.

Authors:  Arata Tsutsumida; Hiroshi Furukawa; Yuhei Yamamoto; Tsuneki Sugihara
Journal:  Int J Clin Oncol       Date:  2005-10       Impact factor: 3.402

Review 4.  Progression of cutaneous melanoma: implications for treatment.

Authors:  Stanley P L Leong; Martin C Mihm; George F Murphy; Dave S B Hoon; Mohammed Kashani-Sabet; Sanjiv S Agarwala; Jonathan S Zager; Axel Hauschild; Vernon K Sondak; Valerie Guild; John M Kirkwood
Journal:  Clin Exp Metastasis       Date:  2012-08-15       Impact factor: 5.150

5.  Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma.

Authors:  Scott R Dalton; Pedram Gerami; Nicholas A Kolaitis; Susan Charzan; Rob Werling; Philip E LeBoit; Boris C Bastian
Journal:  Am J Surg Pathol       Date:  2010-02       Impact factor: 6.394

6.  Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma.

Authors:  Rajmohan Murali; Alistair J Cochran; Martin G Cook; Joseph D Hillman; Rooshdiya Z Karim; Marc Moncrieff; Hans Starz; John F Thompson; Richard A Scolyer
Journal:  Cancer       Date:  2009-11-01       Impact factor: 6.860

7.  Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma.

Authors:  Jeffrey E Gershenwald; Robert H I Andtbacka; Victor G Prieto; Marcella M Johnson; A Hafeez Diwan; Jeffrey E Lee; Paul F Mansfield; Janice N Cormier; Christopher W Schacherer; Merrick I Ross
Journal:  J Clin Oncol       Date:  2008-07-07       Impact factor: 44.544

8.  Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Authors:  Jeffrey E Gershenwald; Richard A Scolyer; Kenneth R Hess; Vernon K Sondak; Georgina V Long; Merrick I Ross; Alexander J Lazar; Mark B Faries; John M Kirkwood; Grant A McArthur; Lauren E Haydu; Alexander M M Eggermont; Keith T Flaherty; Charles M Balch; John F Thompson
Journal:  CA Cancer J Clin       Date:  2017-10-13       Impact factor: 508.702

9.  Lower tumour burden and better overall survival in melanoma patients with regional lymph node metastases and negative preoperative ultrasound.

Authors:  Gasper Pilko; Janez Zgajnar; Maja Music; Marko Hocevar
Journal:  Radiol Oncol       Date:  2011-09-22       Impact factor: 2.991

10.  The prognostic value of lymph node cross-sectional cancer area in node-positive breast cancer: a comparison with N stage and lymph node ratio.

Authors:  Yanxia Li; Earle Holmes; Karan Shah; Kevin Albuquerque; Anna Szpaderska; Cağatay Erşahin
Journal:  Patholog Res Int       Date:  2012-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.